Sign up to get notified by email when a press release has been published on this site. You can also join our mailing list to stay up to date with all things Canopy Growth. You can unsubscribe at any time by using the unsubscribe link at the bottom of our emails.
Canopy Growth to Acquire MTL Cannabis; Transaction Expected to Create Canada’s Leading Medical Cannabis Business and Enhance Capacity to Serve Growing International Demand
This news release constitutes a “designated news release” for the purposes of Canopy Growth’s prospectus supplement dated August 29, 2025 to its short form base shelf prospectus dated June 5, 2024 All financial amounts in this press release are expressed in Canadian dollars. Highly accretive business combination expected to generate significant run-rate synergies of…
Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment
New high-performance AIO vapes and infused pre-roll variety packs further Claybourne’s continued growth as one of the fastest-rising brands[1] in Canada’s adult-use market SMITHS FALLS, ON, December 4, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve…
Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels
Expanded formats strengthen Canopy Growth’s medical offering as patient demand rises SMITHS FALLS, ON, November 18, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability…
Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet
Canada adult-use revenue up 30% in Q2 FY2026 and 37% year-to-date, reflecting the benefits of our focused commercial strategy and more disciplined execution Canada medical revenue up 17% in Q2 FY2026 and 15% year-to-date, marking another standout quarter for growth $298MM cash and cash equivalents, which exceeds debt balances by $70MM at September 30, 2025;…
Canopy Growth to Report Second Quarter Fiscal 2026 Financial Results on November 7, 2025
Smiths Falls, ON, October 24, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2026 ended September 30, 2025 before financial markets open on November 7, 2025. Following the release of its second quarter fiscal year 2026 financial results, Canopy Growth…
Canopy Growth Announces Results of Annual General and Special Meeting of Shareholders
SMITHS FALLS, ON— October 14, 2025 — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, is pleased to announce today the voting results from its Annual General and Special Meeting of Shareholders convened on September 26, 2025…
Canopy Growth Announces DOJA as Dedicated Canadian Medical Facility
Kelowna site to produce craft cannabis under the DOJA brand exclusively for Spectrum Therapeutics patients, advancing Canopy Growth’s commitment to Canada’s medical market SMITHS FALLS, ON, October 8, 2025 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve…
Canopy Growth Corporation Announces Adjournment of Annual General and Special Meeting of Shareholders Due to Lack of Quorum
Annual General and Special Meeting of Shareholders of Canopy Growth to be reconvened on October 10 at 1:00 PM ET Canopy Growth shareholders now have until 1:00 PM ET on October 8 to vote Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by…
Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Shareholders now have until September 26, 2025 at 9:00 AM ET to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with voting your shares please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail at assistance@laurelhill.com Smiths Falls, ON, September 24, 2025 — Canopy Growth…
Canopy Growth Urges Shareholders to Cast their Vote for the Upcoming Annual General and Special Meeting Today
Shareholders are encouraged to vote well in advance of the proxy deadline on September 24, 2025 at 1:00 PM ET The Board of Directors of Canopy Growth recommends shareholders vote FOR each proposal Your vote is important! If you need assistance with voting your shares, please contact Laurel Hill Advisory Group at 1-877-452-7184 or by e-mail…
Sign up to get notified by email when a press release has been published on this site. You can also join our mailing list to stay up to date with all things Canopy Growth. You can unsubscribe at any time by using the unsubscribe link at the bottom of our emails.